Compartir
Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33 (en Inglés)
U. S. Government Accountability Office ( ; U. S. Government Accountability Office ( (Autor)
·
Bibliogov
· Tapa Blanda
Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33 (en Inglés) - U. S. Government Accountability Office ( ; U. S. Government Accountability Office (
$ 47.412
$ 59.266
Ahorras: $ 11.853
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Viernes 02 de Agosto y el
Martes 13 de Agosto.
Lo recibirás en cualquier lugar de Argentina entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Biological Warfare: Role of Salk Institute in Army's Research Program: Nsiad-92-33 (en Inglés)"
Pursuant to a congressional request, GAO reviewed an Army contract laboratory's development and production of vaccines to protect U.S. forces against biological warfare threats, focusing on whether the: (1) contractor developed and produced vaccines against biological agents recognized and validated as warfare threats; (2) contractor was the Army's only viable means of developing and producing such vaccines; and (3) contractor's fees for the use of its facilities complied with applicable federal regulations. GAO found that: (1) the contractor spent 17 percent of the $17.7 million in Army payments on work clearly related to biological agents validated as warfare threats; (2) the contractor spent 33 percent of payments on work that applied to biological agents and diseases not related to warfare and 50 percent of payments on diseases not related to warfare; (3) commercial vaccine producers indicate that there are not viable alternatives to contracting since there is no commercial market for such vaccines in the United States and vaccine producers lack the facilities needed to produce them; (4) although the Army's current in-house capabilities are not sufficient to meet the demand for biological warfare vaccines, the Army could improve research and expand its research and development laboratories to meet vaccine production needs; and (5) the Army paid the contractor $5.5 million more in fees than applicable federal regulations permitted, by following cost principles for commercial organizations instead of those for nonprofit organizations.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.
